Testimony – Episode 8: A Transmission / En sändning

Testimony Episode 8 — A Transmission
Episode 8 — A Transmission / En sändning
EN SV
Snowy panorama of Longyearbyen, Svalbard, with red wooden houses, a red church, old coal-mine structures and a chimney by the fjord.

Longyearbyen, Svalbard, 29–31 March 2018. An overnight train from Stockholm Central, a flight from Oslo, two nights at Funken Lodge. The old coal-mine towers still stand above the town, left where the work stopped.

An Accident, Mid-Story

Svalbard was a test, in its way: could a body that had spent months under treatment still stand two nights near the North Pole and call it a holiday? It could. I came back.

But coming back to work wasn’t the same as coming back to strength. That spring the tiredness had a rhythm of its own. It never announced itself; it was just a lower ceiling than before, higher some days than others, with the ordinary pressure of a shift pressing against a body that hadn’t fully caught up with itself yet. Nothing anyone would have flagged. Just a man doing his job a little less sure-footed than he used to be, and not thinking much of it, because what else was there to do but keep working.

Wednesday, the 30th of May, 2018. Around eight in the morning.

I was backing a cart out of the aisle. 2L 21-23 was the kind of location number you only ever read off a shelf label and never think about again, until it becomes the address of something. A blue cart, BV, loaded with three boxes that were heavier than they looked. Ordinary work, the kind I’d done a thousand times. Except that spring, “ordinary” was carrying more than it used to.

The cart caught. Not the whole cart, just its corner, hooking against the edge of the shelf as I pulled it back. And my little finger was exactly there, in that corner, in the half-second the cart and the shelf both wanted the same space.

I drew it the next day, when my chief needed to write a short report on the accident for Arbetsmiljöverket, the Swedish Work Environment Authority. That’s the normal procedure after any accident at work. The aisle, the shelves, the cart, an arrow for the motion, an asterisk for the exact point where it happened. I drew it with my left hand, the one with the tremor, the way you sometimes have to draw a thing to believe it happened the way it happened. Two lines of shelving, one cart, one small mark where a corner met a corner. Small enough to fit on a page. Large enough to end in a cast.

Hand-drawn diagram in Swedish on lined paper of the 30 May 2018 workplace accident: a blue cart backing out of aisle 2L 21-23 between shelves, with a star where it caught.

The drawing made the next day: the aisle, the shelves, the cart, and the exact corner where it happened.

I went home that same day, after more than thirteen hours at the hospital. That’s the procedure, though I didn’t really know it then; this accident was the first time I’d come in as an Akutmottagningen patient, an emergency case. I had to carry the pain in my finger from the morning until I finally got treatment that night.

Close-up of a hand with a small bleeding wound on one finger, just after the accident and before treatment.

The finger right after: the fracture, and the small wound it left.

I left with sick leave certified through the 10th of June, and a small backup prescription for something stronger than Alvedon in case the pain didn’t settle on its own. A referral had already been faxed for a follow-up about a week out, though no appointment slot existed yet when I left, and another referral was written for a control X-ray. The plan on paper: a week in the cast, then four weeks in a splint.

A forearm and hand in a white cast, held in a brown striped scarf used as a sling, the night of the accident.

That same night: set, and in its cast.

On the 21st of June I went back for the cast to come off and an X-ray to check what was underneath. Occupational therapy started that same day, once a week at KUS Huddinge through the 3rd of August; after that I carried it on myself at home. A doctor’s certificate followed a few days later, making the time off official. By the time I clocked in again, on the 3rd of September, I had been away from work for more than three months.


I don’t know if I’ll ever be sure whether a stronger, more rested version of me would have kept that cart from catching at all. Maybe it was nothing. A corner, a shelf, bad luck, the kind of thing that happens to anyone on any Wednesday. But I know what that spring felt like from the inside: still finding my footing after treatment, tired in a way that came and went, working through it because that’s what you do. The accident wasn’t the cancer. But it happened in a body that the cancer, and the year spent fighting it, had quietly left less sure of itself than before.


My boss had a way of putting it that I’ve never forgotten: “Du har tur av otur.” You got lucky from the unlucky.

He wasn’t wrong. In eight-plus years in Sweden, I had never once taken a long summer holiday, not the kind other people take for granted. That summer of 2018, an accident gave me what nothing else had: a whole summer off, in the warmest part of the year, on doctor’s orders. A holiday I never would have booked for myself, handed to me by a cart that caught on a shelf.

The finger healed the way fingers do, which is to say not quite back to how it was. When I returned on the 3rd of September it still didn’t bend or grip the way it used to, so I kept doing the exercises at home, the way the therapist had shown me. And then it occurred to me: why only at home? The warehouse itself was full of practice. Every box lifted, every label scanned, every cart handle gripped became another repetition. The workplace that broke the finger became the place that finished retraining it.

What it left behind was smaller than a diagnosis and stranger than a lesson: the only long summer I’ve had here, and I owe it to an accident.


The Site That Didn’t Answer

The cast came off on the 21st of June, and occupational therapy ran weekly into August. The sick leave itself ran on until the 3rd of September, so the cart and the aisles, the ordinary rhythm of a shift, were still ahead of me that summer, not behind. But the other thread of that year hadn’t paused for any of it. It never did.

On the 23rd of July, a routine blood test came back with one number outside its usual range: white blood cells, higher than standard. Not dramatic on its own. The usual explanations are ordinary ones: an infection, some inflammation, a course of steroids, or physical and psychological stress such as an acute trauma, surgery or hard training. I had none of the other signs that usually ride along with it. No fever, no unexplained weight loss, no night sweats, nothing beyond the ordinary tiredness of that summer. Just the number, sitting there on its own.

I’ve wondered since whether that’s what it was. Seven weeks out from a fracture, still going every week to retrain a hand that didn’t quite know what to do with itself yet. Maybe some part of the body doesn’t fully distinguish between a threat that’s over and one that’s still being worked through. Maybe it was still on alert, still treating the repair as unfinished business. I can’t prove it. But of all the ordinary explanations on the list, it’s the one that fits the shape of that summer best: a body doing two kinds of healing at once, and one of them still showing up in the numbers.

Three days later, on the 26th of July, I was back at the hematology clinic. Eight doses of Mabthera by then, a full course, the kind of number that starts to feel less like treatment and more like a season of its own. The scan after the fourth dose had shown a response everywhere the disease had been found: prostate, urinary tract, bone marrow. This scan, after the eighth, told a quieter story. Everywhere else, the same good news held. One place didn’t move. The prostate was still enlarged, the same size it had been last time. It was the one site that hadn’t answered. The white cell count from three days earlier was noted too, mildly elevated, filed without alarm. Stable, on the whole, was still the word for it.

Screenshot of a Swedish clinic note from 26 July 2018, the follow-up after eight doses of Mabthera for marginal zone lymphoma.

The clinic note from 26 July 2018, follow-up after Mabthera x 8. “Eko mår väl”: Eko is doing well. Weight stable, no night sweats, no fever. And, almost in passing, the catheter every other day since April.

Screenshot of the same clinic note's assessment: a response everywhere except the still-enlarged prostate, and a referral for a new biopsy.

The assessment: response at every site except the prostate, still enlarged. A new referral to Urology for another biopsy, “för att bekräfta diagnos”, to confirm the diagnosis.

By then the catheter had already become part of daily life, every other day since April. A prescription had run out and I hadn’t gotten around to renewing it, and a body that had been managing well enough on its own stopped doing so, quietly enough to ignore. It fit, somehow, alongside everything else that year: the treatment, the accident, the cast, now this. You find a way to carry what’s in front of you.

So a new referral went out, back to Urology, for another biopsy. This time it was aimed at that one stubborn site, to confirm what the scan couldn’t settle on its own. A blood test came first, timed carefully: a few days’ wait after the exam, so the numbers would read true. A week after that first elevated count, this second one, PSA, also higher than standard, came back and settled the direction: the biopsy would go ahead.


The Good News

The referral went out in July, aimed at the one site that hadn’t answered. It took until September to get an answer of its own.

On the 17th of September, 2018, a letter arrived that didn’t announce itself as an ending, and wasn’t one. It was just one actor, quietly, taking a bow and leaving the stage. The prostate, one of three addresses the disease had occupied since the diagnosis, came back clear.

“Man kan ej finna några lymfomförändringar där.” No lymphoma changes found there. A few lines further down, the Urologiska mottagningen closed its part of the case: no further controls planned on their end, though hematology might still be in touch.
Swedish letter from the urology clinic, 17 September 2018, saying no lymphoma changes were found in the prostate samples.

The letter from Urology, 17 September 2018. “Detta är naturligtvis bra.” This is naturally good.

I read it twice. Not because it was complicated; it wasn’t. It was the kind of letter that fits in an envelope without needing a second one. I read it twice because good news, after enough waiting, doesn’t always land the way you’d expect. Not relief exactly. More like a held breath finally noticing it had somewhere to go.

It wasn’t the whole answer. Three addresses, and this letter only closed the book on one of them. Urology was done asking; hematology, the letter said plainly, might not be. I understood that even as I read the good part. One quiet section of a longer story had ended well. The rest of the story kept going, the way it always had. Not fixed, just steady.

Still, a letter that opens with “Bästa Munoraharjo!” and closes with no further controls needed here is a letter worth keeping. I did.


Back to Solna

A week and a half later, on Friday the 28th of September, I was back at Solna for the follow-up that Episode Seven left waiting behind a closed door. The booking letter named Kristina Sonnevi, the doctor whose name had stood behind every other doctor’s note so far. But the doctor across the desk that day was another hematologist, Hanna M. Ingelman-Sundberg. Even the appointment that was supposed to gather everything together arrived with one more new face.

What lay on that desk was the whole year: the April scan, the July note, the letter from Urology eleven days earlier. And one smaller thing I noticed most of all. The white cell count that had sat elevated since July, unresolved through August, was back where it belonged by the time I walked in. Whatever nudged it up that summer, whether the fracture, the retraining or some quieter cause never pinned down, had settled on its own, filed without needing a name.

Two threads that had been running since summer, the one stubborn site and a number that wouldn’t explain itself, both closed out within the same eleven days. Not because anything dramatic happened. Because enough time had passed, and the body, given room, did what bodies do. What remained was not treatment but watching.


Post-Treatment Life

The catheter that started as an inconvenience in April 2018 didn’t go away when the rest of the year’s threads tied off. It became a fact of daily life instead: every other day, then just daily life, the kind of detail you stop mentioning to people because it stopped feeling like news. It ran that way through 2018, into 2019, into 2020. Around it, everything else kept its ordinary shape: festivals, the Sigtuna Christmas market, Christmas the way Christmas always looks. It took a second prostate operation, in September 2020, before I could start to free myself from it.

Horses grazing in a dry summer meadow at a Swedish horse farm under a heavy grey sky.

A summer afternoon at a horse farm. Life after treatment kept its ordinary shape: open fields, grazing horses, a sky that couldn’t decide.

Underneath the ordinary shape, a quieter rhythm kept time. Blood drawn on a schedule nobody outside a hematology department would ever notice: May 2019, June 2019, June 2020, again later that June, August, September. Watchful waiting isn’t a dramatic phrase, and it isn’t meant to be. It’s a lab slip, filed, followed by nothing, which is exactly the point.

A camera and a green spotting scope on tripods by an autumn lake, with a manor house and farm buildings on the far shore.

Camera and spotting scope set up by the water in autumn. Birdwatching is mostly patience: you set up, you watch, you wait for something to move. Watchful waiting, of a gentler kind.


The Pandemic Years

Then the world changed shape around the waiting.

In March 2020, Covid-19 reached Sweden. On the 16th of that month, the Public Health Agency, Folkhälsomyndigheten, asked everyone aged 70 and over to limit their contact with other people as far as possible. No shops, no crowded buses, no visits. I wasn’t seventy; I was 57.

But age wasn’t the only way into the risk group. A blood cancer, and a body that had spent months on Mabthera, put me inside it just the same. Mabthera works by clearing out part of the immune system. On paper I was “stable”. In a pandemic, stable and safe were not the same word.

So I stayed home. For weeks at a stretch, I lived behind my own front door and kept every contact I didn’t strictly need at arm’s length. It wasn’t panic. It was what I had done since the diagnosis: read what the authorities said, work out what it meant for a body like mine, and build a routine that lived up to it.

People queuing with space between them outside a shop in Huddinge centre, April 2020, early in the Covid-19 pandemic.

A queue outside Systembolaget in Huddinge, April 2020. People had started standing 1.5 to 2 metres apart. Nobody had told us how to live yet, only how far apart to stand.

Masks weren’t new to me. Whenever I had influenza or anything like it, I wore one, so putting one on to go out, for groceries or just for exercise, came automatically. What changed was the scale. I bought masks in bulk and in many types, kept some in my bag so I always had one wherever I went, and a reserve at home. At one point I even bought a full-face respirator with goggles, the kind that looks ready for a nuclear war, just to find out which mask would really keep the virus away from me.

Close-up of the author wearing a full-face respirator with blue-framed goggles and twin filter cartridges, at home in May 2020.

Which mask really keeps a virus out? At home, May 2020, trying the full-face respirator: ready, it seemed, for a nuclear war.

The stress was real anyway. When the thing you’re guarding against is invisible, you’re never quite sure the guarding is enough.

One habit I already had helped more than ever. Since the lymphoma, I had been getting my vaccinations every year, sometime between September and November, as regular as the leaves turning. I took every vaccine I was offered: influenza every autumn, the pneumococcal vaccine against pneumonia, and, once it existed, the vaccine against Covid-19. In those years, that autumn appointment stopped being a routine and became part of the armour.

The watchful waiting didn’t pause for any of it. Blood was still drawn in June, August and September 2020. The second prostate operation, the one that finally began to free me from the catheter, happened that September too, in the middle of it all. The day before I was admitted, I had to take a Covid test at KUS Huddinge.

Work, meanwhile, wanted me back. My chief offered me money as an incentive to come in again in person. I understood why: a warehouse doesn’t run from a kitchen table. But getting there meant public transport, and public transport meant exactly the kind of crowd I’d been told to avoid.

So I solved it the only way that made sense to me. In March 2020, I ordered an electric bicycle from Biketown.se, an online shop in Falun, Dalarna. Then I waited. It didn’t reach me in Huddinge until May, two months later. It seemed everyone had had the same idea that spring, and the whole supply chain was waiting with me.

In between, I borrowed someone else’s e-bike. Its battery was in such poor shape that every ride came with a small calculation of whether it would get me home.

A black electric bicycle with pannier bags on a grassy hillside, with a Canada goose standing beside it.

The e-bike from Falun, with a Canada goose inspecting it. Bought in the pandemic so I could get to work without a crowded bus, it became something more: freedom I could pedal.

Back at the warehouse, the precautions came with me. For months I wore a mask every day at work, uncomfortable as it was, and everywhere else I went. In my pocket I always carried hand sanitiser and packs of sterile wipes. They weren’t only for my own hands but for everything I touched: keyboard and mouse, tools, my work table, the cart handles, whatever passed through my hands in a shift.

The bike from Falun was made for summer roads. So in August 2021, I ordered a second one, a winter e-bike, from Banggood.com. From that winter on, the ride to work no longer depended on the season.

In late October 2020, the special advice for people over seventy and for risk groups was lifted. From then on we were asked to follow the same rules as everyone else. The virus hadn’t gone anywhere, of course. The caution simply became mine to carry.

Rows of empty blue seats inside a Stockholm commuter train heading for Flemingsberg, October 2020.

A near-empty commuter train, next stop Flemingsberg, October 2020. The crowds I had been told to avoid had mostly stayed home too.

The pandemic changed how the hospital kept watch, too. On the 20th of October 2021, a letter from Solna booked a different kind of appointment: a videobesök, a video call. It was set for Friday the 5th of November at ten in the morning, with a doctor I hadn’t met before, Sophia Maassarani.

Blood was drawn a few days ahead, as always, the one part that still needed a body in a room. Then an app on my phone replaced the waiting room. BankID confirmed it was really me, and a camera and microphone stood in for a chair across a desk. Three years on from the last thing this series told you about directly, I was still being checked on, just through a screen now instead of a corridor.

That’s the shape watchful waiting settles into, eventually. It isn’t an emergency revisited, just a standing appointment with a body that once surprised everyone, including itself.

And the virus itself? Thank God, it never reached me. I tested at least twice during those years, both times at home: a swab, a small plastic cassette, fifteen minutes on the timer. Each time, a single line. Negative. I still have a photo of one from March 2022, the cassette beside my watch as it counted down, as if I needed proof that I had come through.

A negative Covid-19 antigen home test with one line at C, next to a smartwatch showing a finished 15-minute timer, March 2022.

A home antigen test, March 2022. One line at C, none at T: negative. On the watch, fifteen minutes, “Klar”.


What Stayed: The Diet, Years Later

The campaign didn’t need to run at wartime numbers forever. Once the scale stopped being an emergency, the 3,000-plus-calorie days stood down on their own. But something from that stretch never fully left. Walk into the kitchen even now and the same cast is still reporting for duty, just working a quieter shift.

Bulgur, mannagryn, couscous: whole grains that showed up because they were cheap, filling and easy on a stomach that had already been asked for a lot. Pumpkin seeds, sunflower seeds, flaxseed, chia and sesame, measured out in small spoonfuls of what a dietitian’s brochure calls “nutrient-dense”, which back then just meant more without eating more. Peanuts, bananas, Marie biscuits, coconut milk, herring, cooking margarine, a carton of meat broth: the unglamorous backbone of meals a body could actually get through.

And beside them, still, the supplements. Supreme Mass, the same weight-gain formula from the fight to hold ground. Whey-80 protein powder. Protein bars from Star Nutrition and Goodlife, the kind you carry in a bag the way other people carry gum.

A cluttered table at night with a tea mug, a tablet, paper towels and jars of supplements and pharmacy products.

A memory: the table. Tea, supplements, a tablet for reading everything I could find. The emergency kit that slowly became an ordinary kitchen.

None of it stayed for nostalgia’s sake. It stayed because the habit outlived the reason for it. What started as ammunition against a number on a scale became, over the years, simply how I eat. It’s proof that “normal life” doesn’t always mean putting everything back the way it was. Sometimes it means keeping the parts of the emergency that turned out to be good for you, long after the emergency itself is over.


Closing the Series

Eight episodes. A diagnosis: a stage IV lymphoma scattered across three addresses in one body. Treatments and scans, and a hand caught in a shelf on an ordinary Wednesday. A catheter that became routine, a letter that closed one thread and left others open, a pandemic spent behind my own front door, and years of watchful waiting that are still, quietly, watching.

I didn’t write this as a medical record. I wrote it because somewhere in Huddinge, in Solna, in a country I’ve now called home for more than sixteen years, a version of me needed to build something out of what was happening to him: a system, a set of tools, a way of staying informed enough to own his illness instead of just enduring it. Medical tools. Digital ones. A diet rebuilt from scratch and, years later, still in the kitchen. A creative life, this website and this series, that kept running the whole time. Not despite the treatment but alongside it, because stopping it never felt like the right kind of rest.

None of that was passive. I want to be honest about that, even now: I didn’t wait for this to be over. I read everything I could get my hands on. I asked questions in a language that wasn’t my first, in a healthcare system that wasn’t the one I grew up in, mostly on my own. And I’m still here. Not just in the biological sense the blood tests keep confirming, but as myself.

And yet this is not an ending, not really. I have to close Testimony with this eighth episode, but my journey with lymphoma never quite ends. Like millions of people who have lived through cancer, I live with a small margin: a life after cancer can one day meet cancer again, the same kind or another. I have no precise idea what lies ahead. But two things I know for certain today. First, my marginal zone lymphoma remains under watchful waiting, checked on, still quiet. Second, since I turned sixty, a letter from RCC Stockholm Gotland has arrived every second year, as it does for everyone in Sweden between 60 and 74. It offers a free home test for hidden blood in the stool, an early check for cancer of the colon and rectum. The latest one came this August. I’ll take it the way I’ve taken everything else: read it, understand it, do it.

A white mute swan running across the water with its wings spread as it takes off.

A mute swan running across the water to take off. Heavy things can still fly; they just need a longer run-up.

So this isn’t a conclusion. It’s a transmission: from me, at every point along this timeline, to whoever’s reading this now with a diagnosis they don’t have words for yet, or a scan they’re waiting on, or a strange, small injury that happened at the worst possible time and turned out, later, to mean something else entirely. You did not choose this chapter. But you get to decide what you build inside it.

Testimony started as a way of telling my own story truthfully. It ends, eight episodes later, as something I’m handing to you.


This is the final episode of Testimony. Thank you for reading. Start again from Episode 1 — The Body Knew First.

EPISODES

Why I Don’t Let AI Write My Testimony

EN SV

— craft, witness, and where the line goes

A note on process. September 2026.

I built a 44-card oracle deck with a machine. I wrote an essay asking whose hand is really on the instrument when an AI helps finish a lyric. I’ve used AI to draft artwork, restructure this whole website, even to sketch the sentence you’re reading right now before I rewrote it in my own words. AbeArtsSweden is, in a lot of visible ways, a collaboration between a person and a set of tools that didn’t exist a few years ago.

And then there’s Testimony.

Eight episodes long and now complete, that series has never touched a language model. Not for structure, not for phrasing, not for the parts that are hardest to get right. It’s the one corner of this site I’ve kept deliberately, stubbornly analog — and lately I’ve been trying to work out why, because “it just feels wrong” isn’t a real answer, even to myself.

Craft versus witness

Here’s the closest I’ve gotten. Most of what I make with AI is craft — music, visual art, an oracle card’s little myth, a think-piece about authorship itself. Craft has room for iteration, for a tool that offers you eight versions of a line and lets you pick the one that lands. An AI in that role is closer to an instrument than a co-author: a synthesizer adds range to a voice without pretending it had the experience the voice is singing about.

Testimony isn’t craft. It’s witness — a record of getting a lymphoma diagnosis in Sweden, of hospital corridors and taxi rides and a body doing things I didn’t ask it to. There’s nothing to iterate on. There’s only what happened, and my job is just not to smooth it into something better-shaped than the truth was.

What fluency costs

This is the part of the AI conversation I think gets skipped in favor of arguing about jobs and copyright, both real arguments, but not this one: a language model is trained to resolve things. Give it a fragment and it wants to complete the sentence, tie off the paragraph, arrive somewhere satisfying. That instinct is exactly what makes it useful for a lyric or a card description — and exactly what would ruin a memoir. Memory doesn’t resolve. It repeats, contradicts itself, gets a date wrong and a feeling exactly right. The awkward, unfinished texture of an actual account is the whole evidence that it’s true. Hand that to something optimized for fluency and you don’t get a better version of the story. You get a more readable version of a different, false one.

So the line isn’t “AI good, AI bad.” It’s narrower than that: AI can stand in for craft, and craft can be shared, remixed, iterated on in the open — which is most of what this site argues, in the Reflections essays and the Whistle of the Signal piece on music authorship. But witness has to stay singular, or it stops being witness. The tool doesn’t know which one it’s holding unless the person using it decides first.

Two answers on the same site

I don’t think this makes me a purist. It makes me someone who had to draw the boundary himself, on purpose, rather than let a default setting draw it for me. Whistle of the Signal and Testimony sit on the same domain, a few clicks apart, and they’re really two answers to the same question — what belongs to a machine, and what belongs to a person alone. I’d rather keep answering that question deliberately, episode by episode, than let it get answered for me by whatever the tool happens to be good at that week.

If you want to see both sides of that line: the Whistle of the Signal essay is where I think out loud about AI and authorship in music. Testimony is where I don’t think out loud about anything — I just tell you what happened.

Ghost in the Machine hoodie design with an AI circuit-face graphic

Sponsored by the AbeArtsSweden shop

Ghost in the Machine Hoodie

The friendly glitch between person and machine, caught mid-flicker. 10% off with code GHOST10 through 14 November.

Shop it on Etsy →

Also on the Inspiration page →

— AbeArtsSweden, September 2026

Testimony – Episode 7: The World They Played In/Världen de spelade i

Testimony Episode 7 — The World They Played In
Episode 7 — The World They Played In / Världen de spelade i
EN SV

This episode moves in three acts: the illness as the world itself, a two-night escape to Svalbard that tested what remained of it, and the scan that later confirmed what the escape had already shown. What follows opens where every performance does — with the cast.

The Casting Call

Symbolic illustration of two flowers, one fresh yellow bloom and one wilting pink bloom, layered with abstract wave patterns

Two blooms, two conditions.

Before any of this had a name, my body was a world I never had to think about — a quiet republic where blood carried oxygen, lymph carried defense, and every cell knew its part without applause. I didn’t know the borders of that world until something crossed them.

Blood cancer arrived first, not as a single villain but as a kind of casting call. Leukemia, lymphoma, myeloma — three different plays that can be staged in the same theatre: the bone marrow, the immune system. Whichever one takes the part, the tell is similar — a tiredness that doesn’t lift, bruises that show up uninvited, infections that linger, glands that swell, weight that goes missing, nights that sweat through themselves. My part was cast for lymphoma.

Lymphoma set the scene in my lymph nodes — small outposts stationed at the neck, the underarms, the groin, that had always worked quietly backstage. Suddenly one of them stepped into the light: a painless swelling that wouldn’t leave. Around it, a chorus gathered — fatigue, fever, night sweats, itching, a weight loss I hadn’t asked for. None of them shouted. They just stayed on stage.

Non-Hodgkin’s lymphoma turned out to be the wider company behind that first appearance — more than sixty understudies waiting in the wings, most of them (mine included) cast from B-cells rather than T-cells. Some of these roles are aggressive: fast, loud, impossible to ignore, demanding treatment now. Others are indolent — they move so slowly you can almost forget they’re part of the play at all, standing still in the wings until they decide to speak.

Mine spoke quietly, and it staged itself outside the usual venue. Marginal zone lymphoma comes in three different addresses inside the lymphatic architecture — nodal, splenic, or extranodal, meaning it sets up somewhere other than a lymph node itself. Mine chose extranodal: MALT lymphoma, named for the mucosa-associated tissue it prefers, and it didn’t stop at one location. By the time it was mapped, it had taken parts in the prostate, the seminal vesicles, and the bone marrow — stage IV, the full company scattered across several addresses of the same body at once. It’s still an indolent role even at that scale: slow, quiet, more interested in sitting still than announcing itself.

The rest of the cast, though — that’s where the story gets crowded. A hematologist reading the shape of the disease and choosing the play’s direction. An oncology nurse administering what the director prescribed. A radiologist reading the imaging for scenes the eye can’t see. Later, a dietitian, a physical therapist, each stepping in for their scene.

And once a month, the same recurring actor walked in through a vein: MabThera. Rituximab, if you want its other name — an antibody that finds lymphoma cells by a signature only it can read, and marks them the way a stage manager marks a light cue, so the body’s own crew can take them down. Four sessions, once a month, the same entrance every time.

I wasn’t alone on this particular stage, even if it felt that way some nights. Elsewhere in Sweden that same year, roughly two thousand people opened this exact kind of play in their own bodies — most of them, like me, well past their twenties. Some of their productions ran fast and aggressive; most, like mine, ran slow. About two in three are still watching the play ten years on.

The curtain never really falls, either. There’s no clean bow where the illness exits and ordinary life walks back on. What comes after is its own act — watchful waiting, they call it clinically, though “waiting” undersells it. Blood drawn on a schedule. Scans booked years apart. A body that learned, once, how quickly the cast can change, and that doesn’t quite forget it.

That’s the stage this next stretch of the story stands on. Not a diagnosis reported from outside, but a world that had actors moving through it — and I was the world they played in.


The Stage Takes a Holiday

The play doesn’t run every night. Even a stage that’s been rebuilt scene by scene needs, eventually, to test itself somewhere the reviews don’t matter — so in late March 2018, a few weeks clear of the last MabThera session, I booked a small production of my own: two nights, one island, no medical business at all. Svalbard, the outline had called it — a mini vacation. But the better word might be a holiday, in the old sense: a holy day, taken on purpose, to see what the body could still hold.

It didn’t start gently. Stockholm Central, 23:14, a Wednesday night train pulling out toward Västerås — car 1, seat 34, the platform lights sliding past the window a minute after departure. Västerås by ten past midnight, then the long unlit stretch south and west that no single ticket covers on its own: a night connection down to Karlstad, the kind of leg you take on trust because the timetable says it works, and somehow it does. By 05:53 a second train was waiting at Karlstad C — car 1, seat 36, this one bound for Oslo — and somewhere past the Norwegian border a green cardboard breakfast box appeared: a slice of rye with salami and cheese, a foil-topped Kulla-mjölk, a juice carton, a wooden fork that wouldn’t survive the meal. Outside, the world turned pale blue, then white — a frozen river, a rail bridge, snowbanks holding their shape in the low early light. Oslo S by 08:44. Flytoget to the airport, 190 kroner, no assigned seat, no drama. Then DY396, 14:00 out of Gardermoen, seat 08A, landing at 17:00 under a Longyearbyen sky that still counted as afternoon.

Funken Lodge hotel building with snow-covered mountains behind, Longyearbyen, Svalbard

Funken Lodge, Longyearbyen — two nights running.

Seat 08A was already taken when I found it. A woman had boarded ahead of me and settled in before I got there, and whatever the ticket said, I wasn’t going to be the one making a scene about three hours and a window view. I said hi, smiled, sat down next to my own seat number instead of on it, and let it go — no complaint, the way I usually don’t. She had a weight to her, though, from the first look. Not size. Something carried, not worn. We didn’t talk much across those three hours — the kind of silence two tired people agree to without negotiating it — but what she did tell me was enough: she worked as a researcher, based right there in Longyearbyen, at the center the whole town quietly organizes itself around. And then I understood the seat, and the weight, both at once. She wasn’t flying in for the view. She was flying in to watch, as closely as the work allows, exactly what was happening to the place she’d chosen to live in. Something in my own chest answered that, hard enough to notice. Same passion, different seat.

I wish I’d asked more — questions, an argument even, anything past the polite minimum, the kind of conversation that costs nothing and gives you a name to remember someone by. But that part of the story is mine to own: I can walk a minus-twenty street without flinching and still go quiet next to a stranger who might have had something worth hearing. Cold, that day, wasn’t only outside the window.

That Thursday — Maundy Thursday, though I didn’t do the math until much later — most of the people I knew were somewhere else entirely. In Sweden, kids were tying scarves around their heads to play påskkärringor, Easter witches, trading crayon drawings for candy door to door, while somebody’s mother started the herring and the Jansson’s Temptation for Saturday’s table. In Norway, whole families were already three days into a week at the cabin, skis leaned against the wall, a thermos of cocoa and a Kvikk Lunsj bar waiting for the next run down, a crime paperback — påskekrim — face-down on the arm of a chair. I was doing something quieter and considerably colder: walking a gritted, ice-glazed street at 78 degrees north, in a cold the thermometer never confirmed but the face reported anyway — somewhere near −18, maybe −22 — past sled dogs, parked 4x4s, and a mountain wall that didn’t so much rise as simply refuse to end.

Icy street in Longyearbyen with Kulturhuset building and mountains in the background

The icy street outside Kulturhuset.

Good Friday, then, though again the calendar kept that quiet at the time. I spent it indoors as much as out: the Svalbard Museum, where a full-mounted polar bear stood roped off behind a hand-written “do not touch,” patient as a retired lead actor; and, a few paces past it in the same building, an art installation by Sonya Kelliher-Combs — pale, cocoon-shaped forms hung from curved wire stems the length of a long white floor scattered with ink-dark blots, the strangest thing I saw all trip, and I still don’t fully know what it was trying to tell me.

Taxidermy polar bear on display at the Svalbard Museum

Patient as a retired lead actor.

Cocoon-shaped forms hanging from wire stems in an art installation by Sonya Kelliher-Combs

“The Things We Carry,” by Sonya Kelliher-Combs.

The bear in that museum was dead, and had been for years, which is its own kind of honesty. What’s alive in Longyearbyen is stranger, and none of it was on display that day. A few minutes’ walk from where I stood, several hundred thousand seed samples from nearly every country on earth sit sealed inside a mountainside — the Global Seed Vault, opened in 2008, built as a planetary insurance policy: if war, blight, or worse ever wipes out a nation’s own crop bank, its seeds still exist here, backed up against exactly that. Not far past it, on a mountain called Zeppelinfjellet, an observatory has been measuring the air itself since 1989 — carbon dioxide, methane, the slow chemistry of everything the rest of the world burns and breathes out, tracked from one of the cleanest, most isolated air samples on the planet. The town below both of them, barely 2,000 people, quietly runs the world’s northernmost university, UNIS, where roughly half the students arrive from somewhere else entirely to study a landscape none of their home countries have. A 1920 treaty, older than any of it, is the reason close to forty-five nations — some of which agree on almost nothing else — are allowed to send scientists here at all, on the one condition that no one ever arms the place. And the reason it all needs watching so closely: Svalbard is warming roughly seven times faster than the global average, the fastest-changing patch of ground on Earth. That makes Longyearbyen less a remote outpost than an early-warning post, years ahead of everywhere else. She hadn’t told me any of this directly. I pieced most of it together afterward, still turning her one sentence over. But it explained, better than a seat number ever could, why someone would choose to live and work at 78 degrees north.

Kulturhuset came next, a different building entirely — library, activity room, and Rabalder, the café and bakery just inside its entrance, where the day’s one proper meal happened, and, it turned out, an actual theatre: a main hall with retractable amphitheatre seating, rigging trussed along the ceiling, its own working machinery for sound and light, built to hold roughly a hundred people at a sitting concert. I hadn’t gone looking for it. The building had been carrying the word literally the whole time, the way the rest of this story had only been carrying it as metaphor.

By evening it was just a hotel room, two bottles of wine standing open on a narrow shelf, a Nespresso machine, glasses that never got fully used. No procession, no vigil. Just quiet, and cold outside the window, and the fact of still being there to notice it.

Wine bottles and a coffee machine on a hotel room shelf

An ordinary evening, two nights running.

Holy Saturday I flew back — DY397, 10:55 out of Longyearbyen, seat 08A again, landing at Gardermoen by 13:50 with Easter Sunday still a day off. It’s a strange day on the Christian calendar, Holy Saturday — the one where nothing happens yet. The tomb is sealed and nobody in the story knows yet whether the play resumes. I didn’t plan the timing. I only noticed, much later, that I’d spent it in the air between one country and the next, which felt, once I saw it, like the right place to have been.

The overland trip undid itself in reverse after that — Oslo, south and east again, back through Karlstad, back through Västerås, the same rails the other direction. It nearly didn’t start at all. Off the plane at Gardermoen, bags barely collected, I found myself half in a panic, pushing across the airport as fast as I could to reach the platform before the train did — the kind of dead run a body eight months clear of monthly infusions doesn’t necessarily still have on hand. I made my seat with maybe a minute to spare before the conductor’s whistle went, sharp and final, like the last word in an argument. I sat there afterward, chest still working hard, and had a thought before I could talk myself out of it: that the whistle wasn’t really telling me to hurry — it was telling me not to bother. Stay, it seemed to say, you’re not finished here yet. I didn’t stay, obviously; the body doesn’t get a vote once the ticket’s booked. But something of me didn’t fully re-board that train either. Some part of it, I think, is still standing on the ice road outside Kulturhuset, still turning over one sentence from a stranger in seat 8A.

I don’t think this was resurrection. That would be too much weight for a two-night trip with a breakfast box in the middle of it, and I’d rather not borrow an ending I hadn’t earned. But it wasn’t nothing, either. This episode opened on a line I meant literally: not a diagnosis reported from outside, but a world that had actors moving through it — and I was the world they played in. Svalbard was the same stage, on tour, running a short unscripted scene far from the theatre where all the diagnoses had happened: walking on ice at minus twenty without flinching, running for a train and making it, sitting three quiet hours beside someone who cared, without quite saying so, about the same warming world I did. Nobody asked me to explain any of it. That was the actual answer to “what kind of normal life can I gain” — not a cure, not a miracle, just a body that could still run when it had to, a heart that could still recognize a kindred passion in a stranger, and a world, mine, still capable of an ordinary evening with a glass of wine in it, two nights running, and wanting, afterward, however reluctantly, to come home.


Reading the Reviews

The referral for the blood draw was filed two days before I left for Svalbard. The CT itself was booked for four weeks after I got back. Read that way, the whole trip sat inside the monitoring cycle like an intermission, not an interruption — the reviews kept coming whether or not I was on stage to read them.

The blood draw itself never left Huddinge, even though the paperwork came from Hematology in Solna. Practical reasons won: Huddinge was central, well-staffed, and under 500 meters from where I lived in Flemingsberg at the time. The routine repeated itself with almost theatrical regularity — leave work early, with permission, bus home, change clothes, walk over, usually timed right at the end of the day, cutting it close to closing on purpose. Take a number. Wait ten, twenty minutes. Get called in when the screen said so. I never missed one, not even the day I was the very last patient through the door. Some evenings I stopped at the ICA Maxi on the way home after, for groceries, like the appointment had just been an errand — which, by then, it more or less was.

Four weeks later, past the ice and the train platforms and the seat 8A conversation I hadn’t finished having, it was the CT’s turn. Nya Karolinska, Eugeniavägen 23 — the same new building Hematology had also just relocated to, everyone in this story converging on the same address without meaning to. Check in at the central cashier, then upstairs to wait. The instructions had arrived ahead of me on paper: a liter of water in the hour before, spaced out, nothing carbonated; no solid food for three or four hours prior. In the room itself, a table that slides slowly through a ring about seventy centimeters wide while the images are taken, a request to hold my breath for part of it, a plastic line set into a vein in my arm so contrast medium could be sent through the blood — the substance that lets a radiologist see the difference between tissue behaving and tissue not behaving, on its way out again through the kidneys before I’d even left the building. Nothing about it hurt, except the needle going in.

Exterior of the new Karolinska University Hospital building in Solna

The new Eugeniavägen building — Hematology, and the April CT.

Photo copied from the Alltid Öppet app.

What a stage performance doesn’t usually have is a critic who reads the show alone, in another room, and files a verdict to someone else first. That’s what a CT is. The radiologist reads the images without me in the room, writes a response, and sends it to the doctor who sent me there in the first place — who then decides what, and when, to tell the patient. I didn’t get an answer that day. I didn’t get one for weeks. The review existed before I ever heard a word of it.

Sitting with Dr. Ebba in July, four cycles further into treatment, she read the old verdict back to me the way you’d quote an old clipping: after the fourth round of MabThera, the scan — this scan, the 27 April one — had shown response at all the stations being watched, including a prostate that had visibly shrunk. That was the sentence that kept the treatment running for four more doses.

I’d been carrying a good review for months without knowing I had one. Svalbard, in the middle of all this, doesn’t look like an interruption anymore so much as the thing the reviews were clearing room for. Blood drawn two days before departure. A scan filed for a month after return. A good notice, delivered late, for a show I’d already gone and taken a short unscripted holiday from in the meantime. That, too, is an answer to “what kind of normal life can I gain” — not that the paperwork ever stops, but that a life can run alongside it instead of waiting for it.

One more entry sits in this particular file, dated later still: a Friday at the end of September, an appointment at the same Eugeniavägen address — only this time the name on the booking was Kristina Sonnevi herself, the physician whose name had stood behind every other doctor’s note so far without her ever being the one across the desk. By then the April scan, Dr. Ebba’s July exam, and whatever the Urology visit that same September had turned up were all sitting on the same desk, waiting for one conversation to hold them together. What was actually said in that room is a story for later.


Read next: Episode 8 — coming soon.

EPISODES

Testimony – Episode 6: Small Doses/Små doser

Testimony Episode 6 — Small Doses
Episode 6 — Small Doses / Små doser
EN SV

Phase 1 had asked everything of the body at once: four weeks, four infusions, hours at a time in a curtained bed. What came after asked something different — four more doses, spread across four months, each one small enough to be over before it had properly begun. This episode covers that stretch: the consultation that set it in motion, the visits themselves, the disciplines that ran underneath all of it, and the holiday that landed, uninvited but not unwelcome, right in the middle.


A Friend in Need

Thursday, 16 November 2017 — appointment 10:00
Karolinska University Hospital, Solna

Dr. Sonnevi had moved. The lymphoma section had concentrated itself at Karolinska’s Solna campus — further from Huddinge, a longer journey, a different set of corridors to learn. I had the appointment card. I had the time. I had a plan.

Leave home at 07:00. Ten minutes on foot to Flemingsberg station. Pendeltåg to Odenplan, then a bus connection to Solna. Arrive with time to register, pay the visit fee at the cashier, find the right department. Simple enough, on paper.

I was at the station before 07:15. I looked at the departures screen.

Postponed.

I waited. The minutes moved. The screen updated.

Postponed again.

I watched my clock and the screen simultaneously now, the way you watch two things when both of them are telling you something you do not want to hear. The gap between where I was and where I needed to be was closing, minute by minute, on a platform in Flemingsberg in November.

A third postponement.

Three cancellations. The pendeltåg was not coming — not in any time that would get me to Odenplan, and from there to Solna, by ten. The whole connection had collapsed. I had to make a decision, and I had to make it now.

I opened my phone. Uber. I requested a car. I waited. No one came. The minutes continued moving. I stood outside the station near the bus stop, watching the road — and then I saw taxis passing. Ordinary taxis. Not the app, not the algorithm, just drivers with cars and the particular unhurried certainty of people who know these roads.

I stopped one.

I opened the door and sat in the back before I had fully decided to. I told the driver where I needed to go — Karolinska Universitetssjukhuset, Solna — and something of why. The appointment. The time. The three postponements on the board behind me.

He listened. And then, calmly — with the particular calm of someone who has heard urgent things before and knows that urgency is best answered quietly — he said:

“Do not worry. I will take you there on time.”

He had an accent I placed somewhere in Eastern Europe. He drove the way his words had sounded — steadily, without drama, with complete confidence in his own knowledge of the route. Twenty-four kilometres from Flemingsberg to Solna. And then, as we moved through the morning traffic, he said something else:

“You can ask SL to reimburse the taxi cost. I will give you the receipt — you can use it as proof.”

I had not known that. In the middle of everything — the worry, the clock, the body that had just spent weeks being treated and was now sitting in the back of a stranger’s taxi trying not to be late for the doctor who had overseen all of it — I had not known that SL had a reimbursement process for exactly this situation.

He knew. He told me. He gave me the receipt.

We arrived at Karolinska Solna with perhaps ten minutes before the hour. But arriving at the hospital was not the same as arriving at the right place. The new Karolinska building was still finding its final form — and the Lymphoma section had not yet moved into it. It remained in the old building, tucked behind corridors that did not announce themselves, that required you to know where you were going or risk losing minutes you did not have.

I moved as fast as I could without running. Through the entrance, reading signs, following the route I had tried to memorise — corridor, turn, corridor again — to registration, then the cashier, the visit fee paid, the paperwork done, and then finally the right waiting room, where I sat down and tried to bring my breathing back to something ordinary.

The wait lasted perhaps two minutes.

Dr. Sonnevi came to the door of the waiting room and called my name.

I stood up.

Later, I filed the SL claim online — carefully, in Swedish, the way I had learned to navigate Swedish systems: precisely, with all the documentation attached. I wrote what had happened: Pendeltåget hade inställt ca. 3 gånger, så för att inte jag kom försenad tog jag taxi. The fare was 989 kronor. The distance was 24 kilometres.

SL reimbursed me.

The driver had been right about that too.

Flemingsberg station, winter

Flemingsberg station, winter. Not necessarily the platform or direction of that particular morning — but the same cold, the same waiting.

The CT reviewed this day, taken after Phase 1’s four weekly doses, showed decreased size of the liver, spleen, and prostate — a partial response. The diagnosis behind all of it: extranodal MALT lymphoma involving the prostate, seminal vesicles, and bone marrow, stage IV. The decision made this day: continue with four more doses, given monthly.

Stage IV

Extranodalt MALT-lymfom, stadium IV. The words sat on the page of the Samordning note, next to my name, in the same plain clinical font as everything else. Stage four. I knew, in the way most people know, that higher numbers in cancer staging are supposed to mean worse. I did not yet know whether that was true here, or how true, or true in what sense.

So I did what I had already learned to do with everything else about this illness: I read.

The number itself, it turns out, describes geography more than it describes danger. In lymphoma staging, stage IV means the disease has been found in more than one place outside the lymph system — for me, the prostate, the seminal vesicles, the bone marrow. Three sites. That is what earns the number four. It says nothing, on its own, about how the disease behaves, how fast it moves, or how it answers to treatment.

And MALT lymphoma, the type in front of my own name, is not a fast-moving disease. It is rare — a small slice of all non-Hodgkin lymphomas — and it is characteristically slow, sometimes so slow it causes no symptoms at all until something else, some unrelated test, happens to notice it.

I found a chart from Sweden’s national lymphoma quality registry, the kind of document that exists specifically to answer the question I was asking. It explained something called relative survival: take people matched for age and sex, and ask what fraction of them would still be alive after five years even without any cancer at all — in the registry’s figure, 80%. Then look at what fraction of actual lymphoma patients were alive at that mark — 60%. Divide one by the other, and you get 75%: an estimate of survival specifically among people for whom the lymphoma, and nothing else, was the only thing that could take them.

I found more, beyond Sweden. A study following people with stage IV marginal zone lymphoma — the family MALT belongs to — put five-year survival at 84.5%, ten-year at 79.8%. The same study looked specifically at what role rituximab played in that outcome. Rituximab was the drug already in my own veins, already renamed on a hospital card as MabThera. And in a separate study of MALT lymphoma outcomes, lymphoma itself was found to be the cause of death in only about 4% of cases across ten years — most of what took people, in that data, had nothing to do with the disease I had just been diagnosed with.

None of this made the word four feel small. But it gave it a shape I could hold instead of one that only loomed. Stage IV was not a countdown. It was a location — three places instead of one — attached to a disease that, by every number I could find, was in no particular hurry, and that medicine already had real, working answers for.

I kept reading. It helped more than I expected it to.


Eight Chairs

The kallelse told you where to go, but paper directions and a real building are two different things.

Cashier first, to register the visit. Then the question of where, exactly, Dagvård was hiding — fifth floor, they said. The lift. Then the corridors — long, the particular kind of hospital corridor that has too many doors and not enough of them labeled, each one closed, none of them announcing which side of it belonged to you. I walked past nurses moving with purpose in both directions, and for a moment I didn’t know which one, if any, was mine.

Then a nurse called my name.

She led me into the room, and the room itself was the first surprise. Nothing like Huddinge. No curtains dividing the space into small private worlds — here it was open, eight chairs arranged across it, each one adjustable, somewhere between a chair and a bed depending on what a body needed that day. Just a little wider than I was. I sat down, found the angle that felt right, and she left me there to wait.

Karolinska Solna corridor

Karolinska Solna, the corridor between the entrance and the room — the one with too many doors and not enough of them labeled.

When she came back, she came back complete — a full cart, every instrument and medicine already gathered, nothing left to fetch twice.

First, blood. A sample, the way it always started. And then the part I still find strange to describe: the treatment itself. A small needle. MabThera, into the abdomen. A few seconds, start to finish.

A few seconds. Where Huddinge had asked six hours of me — the drip, the curtain, the shaking, the blanket — this asked six months’ worth. I sat with that contrast every time it happened, and it never stopped feeling strange.

They kept me a while after, watching for any reaction. There wasn’t one. Then I could go.

Back through the same corridors, the same lift, out through the main entrance — and there, close enough to see from the doors, the bus stop. Some visits it took me only a few minutes to catch one. Other times three or four times that, standing in a Swedish winter that did not care how quick the treatment inside had been.

Dose 1 of 4: 21 Nov 2017, subcutaneous, left abdomen (nurse: Charlotta Holmgren). Dose 2: 19 Dec 2017, right abdomen (Siv Södergren). Dose 3: 16 Jan 2018, right abdomen (Sara Mosell). Dose 4: 13 Feb 2018, right abdomen (Anna Bronner) — plan noted: awaiting evaluation with X-ray, then follow-up at the hematology clinic.
Dagvård A15b schedule card

The actual Dagvård A15b schedule card — 19 Dec, 16 Jan, 13 Feb, all marked MabThera.


Christmas, For Real

We decided, that year, to do Christmas properly — more than we’d ever done Thanksgiving. Not a smaller version, scaled down to match however I was feeling. A real one.

The tree was small — small enough for a shelf, not a room — but it was dressed the way a full-sized one would be: red and gold ornaments, ribbon, a string of small wrapped presents tucked in among the branches themselves, as if even the tree needed something to unwrap.

Underneath and around it, the real presents waited. An Electrolux air purifier, still boxed. A body scale from Beurer — the same maker as the HealthManager apparatus that had been quietly logging my weight and blood pressure every morning since August. A hand vacuum. A new rice cooker. And, further back on the shelf, wrapped in its own paper year after year: the yearly surprise from Byggplast, the same colleagues who had sent flowers to the apartment during Phase 1 without waiting to be asked. Some things, apparently, you can count on.

To the side, past the cards standing upright on the shelf: a bottle of Offley and a bottle of Jack Daniel’s, waiting for later.

Four days earlier I’d had the second of four subcutaneous doses. In four weeks I’d have the third. In between, none of that — just a tree that fit on a shelf, dressed like it didn’t, and a room that had decided, deliberately, to celebrate.

Christmas tree and presents

The tree, the presents, the Electrolux, the Beurer scale, the yearly Byggplast surprise, and the Offley and Jack Daniel’s waiting for later.


The Weight Coming Back

Fifty-nine kilograms. Early September, mid-Phase 1. That number is where the disease and the treatment together had dragged me, and I remember looking at it on the scale and understanding, for the first time in purely physical terms, what was being taken from me.

I decided it would not keep taking.

The walking was one front. The plate was the other, and I fought on it every day, three times a day, with the same seriousness I’d have given an actual enemy. FatSecret logged every gram — nothing eaten without being weighed, nothing weighed without being entered, nothing entered without being checked against a line I would not let myself fall beneath: 2,500 calories, minimum, protein and vitamins and minerals accounted for like ammunition counted before a battle.

Weighed breakfast porridge

Breakfast, weighed and eaten on purpose — the same discipline as Ep.5’s Urtekram ritual, carried into Phase 2.

New Year’s Eve, 2017. Between the second dose and the third. I ate like it was work, because it was: Marie biscuits and banana and honey to start the day, then peanuts and cheese and bread and fries and kebab through the afternoon, and at dinner, alongside the potatoes and more kebab, a scoop of Star Nutrition Supreme Mass — a gainer’s supplement, 461 calories and close to 29 grams of protein, taken the way you’d take medicine, because in every sense that mattered, it was. The day closed at 3,481 calories. Almost a thousand over the floor. I did not eat that much because I was hungry. I ate that much because I refused to lose the ground I’d already taken back.

And the scale kept score. By the 18th of December — three days before that plate — it read 68.9 kilograms. Not 59 anymore. At 175 centimetres, 65 kilograms was supposed to be my number, the BMI-ideal line I was meant to sit on. I had gone almost four kilograms past it.

I won’t call that fantastic. It wasn’t a clean recovery to some perfect target — it was something messier and more honest than that: nearly eleven kilograms fought back from the bottom, and then some, not because I was chasing a number past 65 on purpose, but because worry doesn’t calculate precisely. Under treatment, under the pressure of not knowing, I ate the way you eat when you are afraid of ever seeing 59 again. The uncertainty inside me pushed as hard as the discipline did. Together, they overshot.

Weight chart, 59.0kg to 68.9kg

Weight logged daily via Beurer HealthManager — the actual climb from 59.0 kg to 68.9 kg, Aug–Dec 2017.

Twice a day, still, the same measurements underneath it all — blood pressure, pulse — because a war you stop measuring is a war you’ve already started losing. The apparatus didn’t know it was a holiday, and it didn’t know about ideal weights either. It just kept asking, and by December, whatever the number said, it was no longer the number that had frightened me in September.


Phase 2, in Full

Cross-referencing the clinical notes against the lab and treatment record gives the complete shape of these three months:

DateTimeEvent
16 Nov 201710:00A Friend in Need — CT reviewed (PR), decision to continue 4 more doses monthly
21 Nov 201714:44Dose 1 of 4 — subcutaneous, left abdomen
27 Nov 2017—Lab check
19 Dec 201714:07Dose 2 of 4 — subcutaneous, right abdomen
22 Dec 2017—Lab check
25 Dec 2017—Christmas Day
31 Dec 2017—New Year’s Eve
16 Jan 201813:28Dose 3 of 4 — subcutaneous, right abdomen
22 Jan 2018—Lab check
29 Jan 2018—Lab check
13 Feb 201813:48Dose 4 of 4 — final dose. Plan: await X-ray evaluation, then hematology follow-up

Eight doses in total, four weekly and four monthly, closed out on 13 February 2018 — waiting, now, on what the next scan would show.


Read next: Episode 7 — coming soon.

EPISODES

Testimony – Episode 5: The Quiet Work/Det tysta arbetet

Testimony Episode 5 — The Quiet Work
Episode 5 — The Quiet Work / Det tysta arbetet
EN SV

There is a particular kind of work that no one sees.

Not the work you are paid for. Not the work that appears on a calendar or gets recorded in a system or earns acknowledgment from the people around you. I mean the other kind — the kind you do alone, in the early morning before the day has begun, or late at night after it has ended, or in the quiet hours between appointments when the world outside continues as if nothing unusual is happening.

This is the story of that work.


Flemingsbergsviken Nature Reserve, Huddinge — the landscape where the walking routes began

Flemingsbergsviken Nature Reserve. The water, the reeds, the open sky. This was the world just outside the door.


September came. The four infusions were done.

The weeks of MabThera — the drip, the curtained room, the blood test before each session, the careful rhythm of treatment — had run their course. The medicine had been delivered. Now came the part that no one schedules and no one can do for you: the part where you wait, and watch, and keep the body going while the results take shape inside you.

I was still on sick leave. But in my own mind, I had already decided what these weeks were. Not time lost. Not time stolen by illness. A journey — inward, private, necessary. The kind that asks everything of you precisely because no one else can see it happening.

The quiet work had already begun. And it was not going to stop.


The Morning

Every morning began the same way.

Before coffee. Before the news. Before anything else had a chance to take the day — I went to the apparatus.

Weight. Blood pressure. Pulse. Temperature. Each measurement taken carefully, each value entered into Beurer HealthManager on the laptop, logged automatically with date and time. Then the same data entered manually into Clarus PHR — the personal health record I was building in parallel, my own version of what Karolinska was tracking in their systems.

I had become my own laboratory. A laboratory of one, operating out of an apartment in Huddinge, with instruments purchased one by one and connected by Bluetooth and intention.

The numbers told a story. Not always a dramatic story — often just the ordinary story of a body doing its best under unusual pressure. But I needed to read that story every day. Not from anxiety. From discipline. From the understanding that what you measure, you can manage. What you watch, you can respond to. What you know, you can face.

The data accumulated. Day by day, week by week — a map of my own body drawn in numbers, growing more detailed with every morning I sat down at the table and took the measurements.


The Plate

Then came breakfast.

Not a casual meal. A decision.

Organic gluten-free four-grain porridge — Urtekram, the morning anchor of the self-treatment diet, Huddinge 2017

Every morning. Organic, gluten-free, four-grain. Not chosen by appetite — chosen by what the body needed.

Organic gluten-free four-grain porridge — Urtekram, always organic, certified. The purple package became a fixture on the kitchen shelf. The pink bowl became part of the morning ritual — filled, measured, eaten with the focused attention of someone who understood that food was not comfort during these weeks. It was medicine of a different kind.

I had set a target: a minimum of 2,500 calories per day. Not a guess, not an approximation — a calculated decision, based on everything I had read about what a body under treatment requires to maintain the conditions for recovery. The food scale on the counter was not a detail. It was an instrument, as important as the blood pressure apparatus or the thermometer.

Every ingredient was weighed. Every meal logged. Every nutritional value checked against the daily target. Protein, fibre, vitamins, minerals — not obsessively, but carefully. With the same attention I gave to the Beurer readings each morning.

The porridge was the anchor. Warm, slow, deliberate. It started the day on the right terms — not rushed, not improvised, not surrendered to whatever the morning felt like offering. I chose what went into the body. That choosing mattered more than I can easily explain.

And alongside the food: supplements. For the Omega 3 I needed — high dose, over 1,000 IU — I turned to Carlson Labs, a supplement manufacturer based in Lincolnshire, Illinois. I ordered through LuckyVitamin.com in Pennsylvania, because the concentration available in Sweden was not sufficient for what I needed. Vitamins from Apotea. Each one selected, each one timed, each one part of the same quiet strategy. I did not care about the distance. I did not care about the price.


The Route

After breakfast, I went outside.

This was not negotiable. Whatever the weather. Whatever the energy level. Whatever the body felt like saying about the idea of moving through the world on a September morning in Flemingsberg — I went.

Walking. Sometimes cycling. The routes were the same ones I had always used — paths through the neighbourhood I knew by instinct, roads that led toward the nature reserve and back, the particular geography of Huddinge that I had made my own over years of choosing to live here.

Autumn on Gulavägen, Flemingsberg — the walking route during treatment, September 2017

Gulavägen, Flemingsberg. Autumn arriving on the path. One foot in front of the other — that was the whole strategy.

Autumn was arriving while I walked. The trees along Gulavägen turning gold and amber, the light changing its angle, the air carrying that particular Swedish September coolness that arrives without announcement and stays. I walked into it. I walked through it. I did not walk to feel better, exactly — though sometimes that happened. I walked because the body that was fighting needed to remain a body that moved. Stillness was not an option I could afford.

There is something that happens when you keep moving through a landscape you know well. The mind quiets in a different way than it does indoors. The measurements from the morning become abstract. The appointments ahead become distant. There is only the path, and the light, and the sound of leaves, and the next step.

I carried the illness with me on those walks. I also, for stretches of time, left it behind.

Both things were true at once.


The Scan

Monday, 9 October 2017 — 08:00
Röntgenkliniken, Karolinska University Hospital, Huddinge

Three weeks after the last infusion, the body was read again.

A datortomografiundersökning — a CT scan of the abdomen. Referred by Team Lymfoid öppenvård, Huddinge Hematologiskt Centrum. Dr. Kristina Sonnevi’s name on the kallelse. Eight o’clock on a Monday morning, before the working day had fully begun, before the hospital corridors had reached their ordinary noise.

The scan was a question put to the body: what has changed?

The first CT — back in July, before any of this had a name — had shown what was there. This one would show what remained. Whether the four weeks of MabThera had done what they were designed to do. Whether the wrong cells had retreated, or held their ground, or done something else entirely.

I lay still inside the machine. The machine did what machines do — precisely, without comment, without the particular warmth of the nurses at Hematologiskt Centrum. It simply read. And what it found would determine what came next.

The results would inform the second phase of treatment. A new schedule. A new location. The quiet work was not finished — it was entering a new chapter.


The Email

My brother was following everything from the other side of the world.

We had always been close in the way that brothers are close when distance has become the permanent condition of their relationship — not through daily contact, but through the understanding that what matters to one matters to the other, across whatever distance lies between. He was in Longview, Washington, on the west coast of the United States. I was in Huddinge. The kilometres between us were not negotiable. But the connection was.

I had sent him the Lymphoma app — the one I had found in the Apple Store and Windows Store, published by an American lymphoma research institute. I wanted him to understand not just that I was ill, but what the illness was. What it did. How it behaved. What the treatment was trying to accomplish. I did not want to translate it all into summary and reassurance in a message. I wanted him to have the same source I had, to read the same words, to build the same picture.

He wrote back.

I will not reproduce what he said word for word. Some things belong to the private archive of a family, and his letters are among them. But I will say this: he wrote with the particular combination of directness and warmth that I have always recognised in him. He had downloaded the app. He had read it. He had questions — real questions, not the soft questions people ask when they are trying not to alarm you, but the questions of someone who wanted to understand.

Those emails — his from Longview, mine from Huddinge — became part of the treatment in their own way. Not medicine. Not data. Something harder to measure and equally necessary: the knowledge that someone on the other side of the world was paying attention. Was reading. Was there.

You are not as alone as the apartment sometimes makes you feel.

I knew that. I needed reminding anyway.


The City

Huddinge was not only the place where I was ill.

It was the place I had chosen. The place I had come to — not by accident, not by necessity, but by a series of decisions that had accumulated into a life. And that life did not stop because a lymphoma had appeared in it. It continued, quietly, alongside everything else.

Huddinge Jazz and Blues Festival, Sjödalsparken, Huddinge Centrum

Sjödalsparken, Huddinge Centrum. The Jazz and Blues Festival. Music in the open air. Life, continuing.

Sjödalsparken in Huddinge Centrum — the outdoor stage, the wooden benches, the crowd gathered in the summer air to listen. The Huddinge Jazz and Blues Festival. I had been there before the diagnosis. I would be there again.

I include this not because it happened during the treatment weeks — the timing was its own. But because it represents something I needed to hold onto through those weeks: the knowledge that the city around me was alive, that culture was happening, that music was being played in public parks by people who did not know my name or my diagnosis, and that this was right and good and part of what I was fighting to return to.

Huddinge is not a city that announces itself. It does not have the drama of a capital or the noise of a place that needs to be noticed. It has parks, and commuter trains, and nature reserves at the edge of the residential streets, and festivals in summer where people sit on benches and listen to jazz. It is, in other words, a place where an ordinary life can be lived with genuine attention.

That is why I chose it. That is why I still live here.

And during those September weeks, when the treatment was done and the waiting had begun and the quiet work was the only work there was — I held the image of that park, that music, those benches in the open air, as evidence of what ordinary looked like. As something to walk back toward.


The Radio

FK FM listed on iTunes Apple — Classical category, 330 streams, running from Huddinge 2014–2019

FK FM on iTunes. Classical category. 330 streams. Broadcasting from an apartment in Huddinge — while everything else was also happening.

While all of this was happening — the measurements, the walks, the porridge, the emails from Longview, the appointments at Karolinska — something else was running quietly in the background.

FK FM. My online radio station.

I had built it myself, starting in 2014, out of a desire to broadcast music with intention — carefully selected, carefully sequenced, sent out into the world through a stream that anyone with the right app could find. It appeared in iTunes under Classical, among 330 other streams. It ran from this apartment. From this desk. From a life that was, in 2017, simultaneously managing lymphoma and continuing to create.

I do not think of the radio as a distraction from the illness. I think of it as evidence of the same thing the walks were evidence of, the same thing the porridge was evidence of, the same thing the measurements were evidence of: that the self does not stop when the body is under pressure. That creativity does not wait for health. That the work continues — quietly, without announcement, in the background of everything else — because stopping it would have been a different kind of surrender than I was willing to make.

The radio ran. The body healed. Both things were true, simultaneously, in the same apartment, on the same ordinary days.


The quiet work is not quiet
because it is small.
It is quiet because
no one is watching.
Because it asks nothing
of anyone else.
Because it happens
in the space between
what the world sees
and what actually keeps you alive.

November now.
The light leaving earlier each day.
The apparatus waiting on the table.
The body, still here.
Still working.

The Weight No One Asked About

There came a day — one of the infusion days, somewhere in those four September weeks — when I came home and could not carry it anymore.

Not the illness. Not the measurements or the diet or the walks. Something smaller, and therefore larger.

I was reaching for the sofa — just beginning to put things down, to let myself stop, to allow the exhaustion that had been building since the morning to finally arrive somewhere it could rest — when she came to me with the shopping list.

“Here, if you want to buy some food.”

I looked at it. I looked at her.

And something that had been held very tightly for a long time came loose all at once. I was angry.

I do not remember the exact words. I know they were not gentle. They came from somewhere below reasoning — from the place where months of managing alone had been quietly accumulating, without a proper exit. What came out was not a complaint. It was not even really directed at her. It was the sound of a body and a mind that had reached the edge of what they could carry without being seen.

I am not pretending. This is not a small thing. I need to rest.

Only louder. And with everything I had been holding.

Because this was real: while I was managing the illness, I was also managing the household. The food shopping. The meals. The errands. Two, three times a week. Not because it had been formally decided — simply because that was how things worked, and illness had not renegotiated the terms.

I was not angry at her, exactly. I was angry at the weight. At the invisibility of what I was carrying. At the gap between how serious this was and how ordinary the day still seemed to everyone around me.

The sofa. The list. The moment.

Some things are small enough to hold everything.

That evening, I lay down. Outside the window, the last of the November dark had settled over the rooftops of Flemingsberg. The radio was still running somewhere in the background. The body that had been treated, and walked, and measured, and fed with intention — that body finally stopped.

And in the stopping, something was released. Not resolved. Not healed. But released — into the quiet of an apartment in Huddinge, where the quiet work had been happening all along, and would go on happening, seen or unseen, for as long as it needed to.


The schedule arrived in the post.
Three dates.
Three times: 13:30.
December. January. February.

The arrow on the card meant same.
Same treatment. Same reason.
Same body, carrying the same quiet work
into the dark of a Swedish winter.

You do not ask winter for permission.
You simply put on your coat
and go.

The card sat on the table beside the apparatus. Three more dates. The quiet work was not finished — it was only changing shape, moving into a different season, asking the same thing it had always asked: that I show up, that I measure, that I keep going through whatever the calendar placed in front of me next.


Read next: Episode 6: Small Doses / Små doser — coming soon.

EPISODES

Testimony – Episode 4: The Drip and the Blanket

Testimony Episode 4 — The Drip and the Blanket
Episode 4 — The Drip and the Blanket
EN SV

There is a particular kind of silence inside a daily care room.

Not the silence of peace. Not the silence of rest. It is the silence of a body being worked on — slowly, carefully, drop by drop — while the mind lies very still and watches.

I had been told what to expect. The nurses at Hematologiskt Centrum had explained the process: the IV line, the rate of the drip, the hours it would take. They had told me about possible reactions. Their voices were calm and precise, the way voices become when they have said the same words many times and learned that calm is itself a kind of medicine.

I listened. I nodded. I lay down on the patient bed.

The room was not bright. The overhead lights were kept low, but sunlight reached in from outside — not direct, filtered — and cast soft shadows across the ceiling and walls. It was a gentle light. The kind that does not demand anything from you.

Around each bed, long curtains hung from ceiling rails, drawn closed to make a small private world of each patient. I could not see who was in the next bed. But I could hear him — a voice, low and steady, talking to a nurse on the other side of the partition. We were separated and together at the same time. Each of us inside our own curtained quiet, each carrying something the other could not fully see.

And then the drip began.


25 August 2017.

Besökskort — Hematologen R51-53, Karolinska University Hospital

Besökskort — Hematologen R51-53, Karolinska University Hospital, Huddinge

The first MabThera infusion.

One drop. Then another. Then another.

I had been coming to Karolinska University Hospital in Huddinge long enough by then that the corridors felt familiar. The smell of the building. The particular light. The sound of trolleys in the hallway. These were not strangers around me — they were people I had learned to read, faces I recognised, a team that had walked with me from the first uncertain appointments through the diagnosis and into this room. That familiarity mattered. It was its own kind of ground to stand on.

But familiarity does not make a needle smaller. It does not slow the clock.

The hours inside that bed were still long.


When the needle found the right vein and the drip began, I felt the first drop enter my body. Then another. Then another. Quiet, precise, unhurried. The nurse made sure everything was running correctly, then left me alone behind the curtain.

A minute passed. Then two. Then five.

I lay still, watching the soft shadows on the ceiling, listening to the low voice of the patient on the other side of the partition. The room was calm. The drip was calm. My breathing was calm.

And then, somewhere into the infusion, my body decided it had something to say.

It started as a feeling I tried to dismiss. No. Nothing. It is nothing. But the cold came anyway — not ordinary cold, not the kind you can reason with — a chill that moved from deep inside and worked its way outward. Then the trembling began. Not a shiver. A shaking. The kind that does not ask permission, that does not wait for you to understand what is happening before it takes over your hands, your arms, your whole body.

I had no idea what it was.

I tried to hold still. I tried to tell myself it was passing, that it was nothing, that bodies do strange things and this would stop. But the trembling only grew — uncontrollable, insistent, my hands shaking, the cold moving deeper into my bones with every minute.

And here is the thing I have not yet said: I did not call the nurse immediately. This was my first treatment. I did not know what a normal reaction looked like, and I did not know what an emergency looked like. I had no reference point. So I waited — telling myself it would pass, that perhaps this was simply what the medicine did, that I should not make a fuss over something I did not yet understand. I held on, and I shook, and I said nothing.

Until I could not hold on any longer.

I needed the nurse. I looked around from the bed, trying to think clearly through the shaking — and then I saw it. A button on the wall beside me. Push to call the nurse.

I pushed it. Not calmly. With a hand I could barely steady, with something close to panic moving through me.

She came quickly. Her name was Lisa.

She recognised what she saw — had seen it before, many times before — and she moved without panic, which was exactly what I needed someone near me to do. She stopped the infusion. She gave me doses of Cortisone. When my temperature rose a little, she brought it down with Paracetamol. She did what trained hands do when a body responds in a language they already know how to answer.

And then she stopped beside the bed and looked at me.

“Do you want an extra blanket?” she asked.

“Yes, please.”

I do not know how much effort those two words took. Not much, perhaps. Or perhaps more than they should have. When your body is shaking and the cold has settled deep into your bones and you are trying to hold on to some ordinary version of yourself, even a small request can feel like an admission.

I pulled the blanket around my shoulders.

From that point, Lisa came to check on me every thirty minutes or less — blood pressure, temperature, a few quiet questions — and then left me to sleep again. That went on for about six hours in total. I had no lunch that day. Only a small cup of coffee from the automat in the corridor.

That small exchange — the blanket, the thirty-minute visits, the coffee.

In a room full of medicine and precision and clinical protocol, someone had decided that warmth also belonged there. That the body being treated was still a body that could be cold, still a person who might need something soft against their skin.

I think about that blanket still.


The infusion took several hours.

By the time the drip was done, the light in the room had changed. The shadows had moved. The afternoon had become something else without my noticing.

At some point during those hours I had fallen asleep. The medication had taken effect — quietly, without announcement — and somewhere between the drip and the blanket and the soft shadows on the ceiling, consciousness had simply let go. I do not remember dreaming. I am not even entirely sure the nurse who checked on me was not part of a dream. That boundary — between sleep and waking, between what happened and what I only half-perceived — was not clear then, and it is not clear now.

I had not moved. But something had.

The medicine was inside me now — working, they had explained, to find the wrong cells, the ones that did not belong, the ones that had been quietly growing where they should not have been. The body waging a slow internal war with borrowed soldiers.

And the blood — always the blood — was where that war was being fought. Where the wrong cells had first appeared, where the medicine would seek them out, and where the evidence of progress, or its absence, would eventually show. It was only right that every visit began there.

Before the drip there had been a blood test — blodprov — as there would be before every session. They needed to read the body first, to know where it was, before they could continue treating it. Data before medicine. Numbers before the needle. Each visit began with the same quiet question put to the blood: how are you holding?

Finally, I stood up carefully. Lisa checked on me one last time. I walked out into the corridor.

It was close to four in the afternoon. I was hungry — properly hungry, the kind that reminds you that the body, whatever it has just been through, is still a body with ordinary needs. I found a restaurant inside the hospital and sat down with a plate of salad. I ate quickly, with the focused appetite of someone who has not eaten since morning.

Then I walked. About half a kilometre, on foot, to the ICA Maxi nearby. I had fruits to buy — part of the self-treatment discipline I had already begun building. The errand felt ordinary. It also felt like a small act of defiance: the body that had just spent six hours being worked on, walking now under its own power, buying its own food, continuing its own care.

Outside, the hospital continued its ordinary business. Footsteps. Voices. The low hum of a building full of people doing difficult work. I carried the stillness of the infusion room with me for a while, like something I was not ready to put down.


The Rhythm of the Weeks

That yellow card went everywhere with me.

BESÖKSKORT: Hematologen R51-53.

Four lines. Four dates. Four weeks.

25 augusti — 1 september — 8 september — 15 september.

Every week the same corridor. Every week the same room, the same curtain, the same bed. The blood test first, then the wait, then the drip. The body learning to expect it — not comfortable exactly, but no longer surprised. There is a particular kind of endurance that comes not from strength but from repetition. You simply return. You lie down. You let the drip begin again.

–”– the card reads, for each visit after the first. Ditto. Same as before. Same reason.

behandling MabThera + Prove.

Treatment and test. Week after week. Until the four weeks were done.

But driven by curiosity — and perhaps by a need to feel less like a passenger in my own body — I had decided to make my own journey alongside the one the doctors were managing. To become, in my own small way, both patient and observer.


The Parallel Treatment

And so, quietly, I built my own little clinic — at home, outside the hospital walls.

Before the first infusion — before 25 August — I had already begun something of my own. Not instead of the medicine. Alongside it. A parallel discipline, quiet and daily, that no doctor had prescribed but that I had decided was necessary.

I had purchased apparatus. A blood pressure monitor. A body scale. A food scale. A thermometer. Small devices, each with a specific task, each connected by Bluetooth to a program on my laptop: Beurer HealthManager. Every measurement logged automatically. Date, time, value. The data accumulating day by day into something I could read, something I could follow — a map of my own body drawn in numbers.

Beurer HealthManager — augusti 2017

Beurer HealthManager — blood pressure readings, augusti 2017

And alongside Beurer, a second program: Clarus PHR — Personal Health Record. Where Beurer captured the raw data automatically, Clarus received what I entered manually — the summary, the interpretation, the bigger picture. Blood pressure. BMI. Pulse rate. Temperature. A personal medical file, maintained in parallel to whatever Karolinska was recording in their own systems.

Every morning, almost the first thing after waking, before the day had fully begun: weight, blood pressure, pulse, temperature. The numbers written into the machine. The trend watched carefully. Was it stable? Was it rising? Was something changing that needed attention?

I also watched what I ate. Not casually — with a food scale, with intention, with the understanding that the body fighting lymphoma needed more from me than ordinary habits. Supplements. Adjusted portions. Choices made not by appetite but by what I believed the body needed to endure what was coming each week.

I read everything I could find. Booklets from the hospital. Digital resources in Swedish. And an app I found in the Apple Store and Windows Store — published by an American lymphoma research institute, simply called Lymphoma — which I downloaded and worked through carefully, and later recommended to my brother to download too, so he could understand what I was going through from the other side of the world.

And sometime in the week after the last infusion of this first phase, I did one more thing. I joined Blodcancerföreningen — the Swedish Blood Cancer Foundation. Two hundred kronor. A small act, but a deliberate one. I was not just a patient moving through a system. I was part of something — a community of people who understood this particular weight from the inside.

This was my contribution to the treatment. What I could control, when so much could not be controlled.

And here is perhaps the most telling detail of all. I was on sick leave during those weeks — the diagnosis made that inevitable. But in my own mind, I let myself pretend it was vacation. A private reframing, invisible to anyone else, but important to me. Because this was not time lost to illness. This was a journey — inward, private, necessary. A travel deep inside myself. And journeys, I have always felt, deserve to be taken on your own terms.

Clarus PHR — Personal Health Record

Clarus PHR — Personal Health Record dashboard


The Flowers

Flowers from colleagues at Byggplast — Krya på dig Agus!

From Manuel and all colleagues at Byggplast & Båtpryllar AB — sent to the apartment

At home, there were flowers.

I do not know exactly when Manuel had arranged it — he had not made a point of telling me, had not waited for my reaction. That was his way. He had simply done it: spoken to the others at Byggplast & Båtpryllar AB, gathered something on behalf of all of them, and sent it to the apartment.

A bouquet. With a card.

Krya på dig Agus!
Vi tänker på dig…
Varma hälsningar dina kollegor på Byggplast.

I put the flowers beside the window, where the light reached them. I kept them there until they dried. Long after they had lost their colour, I kept them. Because they were proof of something — that while I was lying in that bed, in that curtained quiet, with that drip running into my arm, people who knew me were thinking about me. Were sending warmth across the distance between their ordinary day and mine.

That matters. It is hard to explain exactly why, but it matters enormously.


That evening, I lay down.

Outside the window, the flowers from Manuel and the others were catching the last of the light — still fresh, still standing, still carrying the colour of the gesture that had sent them.

The blanket from the infusion bed was not with me. But I remembered the weight of it. The way it had arrived after two quiet words.

Yes, please.

Some care comes like that — after a small admission, a moment of letting go. It simply appears, because someone asked, and you answered, and warmth followed.

I held on to that. On the hard days, and there were many, I held on to that.


Episode 5: The Quiet Work

© AbeArtsSweden — Testimony is a personal blog series written in dialogue with memory, documents, and time.


EPISODES

Testimony – Episode 3: The Day She Wrote It Down

Testimony Episode 3 — The Day She Wrote It Down
EN SV

August came the way August always comes in Sweden — quietly, with light that lasts too long and a warmth that already knows it is leaving.

I came home from Karolinska Huddinge on the first of August with a mark on my back and nothing else. The biopsy was done. The waiting was not.

One week, they said.

I counted the days the way you count things when counting is all you can do.


What I did not know — what I could not know — was what was happening on the other side of that silence.

While I went to work. While I made dinner. While I slept and woke and looked at the summer outside my window, something else was in motion.

Dr. Sonevi had not been alone from the beginning. She led a team — a group of doctors whose names I would never fully learn, whose faces I would never fully see. They met in real rooms at Karolinska Huddinge. They met online. They shared findings, exchanged expertise, read the results of my blood, my bone, my cells.

They were looking for a name.

In medicine, a name is everything. Without a name there is no map, no treatment, no direction. The investigations I had carried through July — the CT scan, the bone marrow biopsy, the blood drawn at ten in the morning — all of it fed into a process I could not observe. A conversation about me, happening without me.

I imagine those rooms. The careful language of doctors deliberating. The images on screens. The numbers that mean something only to those trained to read them. Someone saying: look at this. Someone else leaning forward. A conclusion forming slowly, the way certainty always forms — not in one moment, but across many.

By the time Dr. Sonevi sat across from me on the eighth of August, the team had already spoken.


8 August 2017 — 09:15
Karolinska University Hospital, Huddinge

She was the same as before. Calm. Precise. The kind of stillness that is not coldness but something more difficult — a learned steadiness in the presence of fear.

She told me what the investigations had found. She spoke about what was most probable. She used words I was still learning to carry.

It was not yet the final confirmation — there was one more step, one more meeting ahead. But sitting in that room on a Tuesday morning in August, I understood something had shifted. The investigation had become a conclusion. The question had become almost an answer.

Then, at the end of the conversation, Dr. Sonevi looked at me and asked:

“When do you want to start the treatment?”

I did not hesitate. Not for a second.

“As soon as possible.”

She nodded. That was all.

I walked out into the corridor. The summer was still outside. Still ordinary. Still bright.

But I was not the same person who had walked into that room twenty minutes earlier.

I went home. I waited ten more days.


Between knowing almost
and knowing completely —
a distance of ten days.
The same coffee cup each morning.
The same window.
The world continuing
as if it had not heard.

18 August 2017
Karolinska University Hospital, Huddinge — Hematologiskt Centrum, Mottagningen R51

This was the day.

Dr. Sonevi confirmed the diagnosis. The team’s work was complete. The name had been found, agreed upon, documented. She handed me the printed treatment plan — a Behandlingsbrev, a letter of treatment — pages that described, in the precise language of medicine, what was living inside me and what would be done about it.

Mabthera. Once a week. Four weeks. Starting 25 August.

I held the papers.

Then I asked her something I had been carrying since July — since the urologist had first written a word on a referral and handed it across a desk.

“What is the name of my illness?”

She could have pointed to the document. She could have said: it is written here. But she did not.

She took a pen.

And in her own handwriting, in blue ink, across the top of the printed page in my hands, she wrote:

Marginal Zons Lymfom.

Three words. Her hand. My paper.

I still have that document. I have kept it all these years — not as a wound to return to, but as proof of something I needed to hold. That on a Friday in August 2017, a doctor who led a team of people I never met took a pen and wrote the name of what I was carrying.

So that I would know.
So that it would be real.
So that I could begin.


The original Behandlingsbrev from Karolinska Universitetssjukhuset, dated 2017-08-18, with Marginal Zons Lymfom handwritten by Dr. Kristina Sonnevi

The document I asked for. The name she wrote. August 18, 2017.


A name written by hand
is different from a name in print.
Print is the system speaking.
A hand is a person —
saying: I see you.
I am here.
This is what we know.

I walked out of Karolinska Huddinge that August afternoon with the paper in my hand.

And something had shifted inside me — not fear. Not defeat.

I have to fight all out. I have to survive.

That was the only thought. Clear and hard and simple, like a stone dropped into still water.

I went home. And I went to work.

Not the work I was paid for. Another kind.


The Research

I opened my laptop and I started searching and reading.

WebMD — the American medical platform, trusted and thorough — became my first university. The WebMD: Symptom Check app followed almost immediately onto my phone. It was the main resource for learning about MZL — what it was, how it behaved in the body, what the survival numbers said, what treatment paths existed. I read it the way you read something when your life depends on understanding it.

Alongside WebMD, I found Blodcancerförbundet — the Swedish Blood Cancer Association — at blodcancerforbundet.se. Here was the same knowledge but closer to home, in the language of the country I lived in, written for patients like me. Between these two sources — one American, one Swedish — I began to build a picture of what I was facing.

I read everything. Then I read it again. And again. I wanted it inside me — not just understood, but memorized. Owned. If this thing was living in my body, I was going to know everything about it.

Later, as the days passed and my research deepened, I began discovering more tools. One by one, apps appeared on my Apple Store that covered dimensions I had not yet thought to monitor. HeartWatch: to track my pulse. Health Manager Pro by Beurer: connected directly to my blood pressure apparatus and body scale. Oximeter: to monitor my oxygen levels. HealthFit: for overall body data. Kaloriräknaren by FatSecret and Nutricheck: so that every meal, every ingredient, every nutrient could be accounted for.

I had made my own calculation: a minimum of 2,500 calories per day. Not a guess — a decision, based on everything I had read about what a body needs when it is fighting. That is why every meal was weighed. Every ingredient counted. Every nutritional value checked. The food scale on the kitchen counter was not a detail. It was part of the strategy.

Each app was a new instrument in the same orchestra. Together they formed something I had not planned but had built anyway — a complete personal monitoring system, running quietly in the background of every day.


The Arsenal

Then I made lists.

The MabThera treatment would lower my immune system. That much was clear from everything I read. And if my immune system dropped, my apartment in Huddinge could not stay the way it was. A normal home was not good enough anymore. I needed something closer to a sterile environment — as close as one person, alone, without medical training, could build.

I began purchasing, methodically:

For the room — an Electrolux Rapido portable hand vacuum. A portable vacuum with UV light for the mattress and sofa. An Electrolux room air purifier. A mini portable UV surface scanner. A room humidity diffuser. An electronic sensor for humidity, gas, and chemical levels. Bottles of alcohol for every surface. I went through the apartment — every corner, every fabric, every place where something invisible might hide.

For the body — a Beurer body weight scale connected by Bluetooth to Health Manager Pro. A Beurer blood pressure apparatus, also connected. A pulsometer. A food scale. An Oral-B Braun electric toothbrush with its own app. An Apple Watch — monitoring heart rate, movement, and sleep through the night without interruption. A water jar with filter. And a digital microscope — complete with glass apparatus and measurement tools — so I could monitor my own urine at home, the way a small private laboratory would.

For nutrition — I researched every vitamin, every mineral, every food that could support an immune system under pressure. Apotea, Sweden’s leading online pharmacy, became a regular stop. But Sweden was not always enough. For the Omega 3 I needed — high dose, over 1,000 IU, the concentration that mattered — I found it at LuckyVitamin.com, an online health store in Pennsylvania, USA. I ordered across the Atlantic without hesitation.

I did not care about the distance. I did not care about the price.


Blood pressure monitoring at home — Beurer apparatus connected to Health Manager app on tablet, Huddinge 2017

The monitoring never stopped. Not even at home. Not even at night.


The Weight No One Saw

There was something else I carried through all of this. Something private, and daily, and unrelated to the lymphoma — and yet completely inseparable from it.

Since my prostate operation, I had been managing a urinary condition that required me to use a catheter — the LoFric Hydro Kit, a soft medical instrument — to fully empty my bladder. Several times a day. In the morning. At night. Sometimes at work. It was always in my bag, wherever I went, a quiet companion that demanded attention regardless of what else was happening.

I would continue to need it until a second prostate operation in 2020.

So when I speak of building a sterile room and monitoring my body from every angle — I was doing all of this while also managing this. Every day. Alone.

I do not say this for sympathy. I say it because the full picture matters. And because someone reading this may be carrying something similar — a burden that has no visible weight but is always there.


No one saw any of this. No one needed to.

It was between me and the illness.

I was building the conditions for survival — quietly, methodically, alone in an apartment in Huddinge, in the last days of a Swedish August.


The summer outside was still ordinary. The trees along the road to the commuter train. The particular Swedish light of late summer — golden, already tired, already beautiful in the way that things are beautiful when they are about to change.

I had a name now.

And somewhere behind me, in rooms I would never enter, a team of doctors had already set the calendar.

I was not alone in this — even when I felt alone. Even when I cooked dinner for one and counted days by myself and navigated the system of a country that was mine by choice but not by birth.

The medicine was decided. The date was set.

As soon as possible, she had said.

25 August. 09:15.

August was almost over.


Read next: Episode 4: The Drip and the Blanket →

EPISODES

Testimony — Episode 2: The Weight of Waiting

Lymphoma in the urine — Lymfom i urinen

Lymfom i urinen. Min kropp talade redan.
Lymphoma in the urine. My body was already speaking.

There is a particular kind of suffering that has no name in the medical charts.

It is not pain, exactly. It is not fear, exactly. It lives somewhere between the two — in the space between one appointment and the next, in the silence after a doctor has spoken and before you have fully understood what was said.

It is the weight of waiting.

From the 3rd of July to the 8th of August 2017, I carried that weight.

And I carried it, for most of that time, without fully knowing what I was carrying.


3rd July 2017

It was supposed to be a routine visit.

A post-operation control — a check on how the recovery was progressing after the TUR-P. The kind of appointment you go to because you are supposed to, not because you expect anything.

The urologist examined me. Asked the usual questions. And then, towards the end, said something almost in passing — the way doctors sometimes say the things that change everything:

A remiss had been sent. To Hematology. At Karolinska Huddinge.

I would receive a kallelse — a letter of invitation — with the date and time.

That was all. The appointment was over.

I walked out. The summer was outside, ordinary and bright. I did not fully understand yet what had been set in motion. The referral had happened somewhere in a system I could not see — digitally, behind the scenes, between one specialist and another. I had not held a piece of paper with the word on it. I had only heard a sentence.

But the sentence stayed with me.


The Weeks Between

I went back to work.

This is the part that is strange to explain, because from the outside, life looked the same. I went in. I did my job. I came home. The calendar moved forward.

But the body — the body was telling a different story.

Every ten, twenty minutes, I had to pause. A tiredness that was not ordinary tiredness. A heaviness in the breath. A weakness that sat in the bones. I moved through those weeks the way you move through deep water — everything taking more effort than it should, everything a little slower than it ought to be.

I did not know, then, that these were symptoms. I did not connect them to the word the urologist had said. I had just had an operation. I was recovering. The exhaustion made sense — or seemed to. The body had an explanation that felt sufficient, and I accepted it.

Only much later would I understand that the lymphoma had been speaking all along. Loudly, in fact. I had just been listening to the wrong translation.


Manuel

It was a Chilean-Swedish colleague who first gave me a map.

His name is Manuel. He noticed — the way some people simply notice, without being asked — that something was not right. He asked. And I told him what little I knew: the referral, the waiting, the word that had been said but not yet fully explained.

He listened. And then he told me about his wife.

She had had breast cancer. He knew the territory I was about to enter — the appointments, the investigations, the systems, the decisions you have to make before you fully understand why you are making them. He told me what to expect. He told me what to prepare. He told me about the insurance — to check it, to understand it, to make sure it was in order before the treatment began.

I had not thought of any of these things. I did not yet know enough to think of them.

Manuel knew. And he gave me what he knew, quietly, between colleagues, at a workplace where I was still showing up every day and pausing every twenty minutes to catch my breath.

That conversation was a kind of light. Not the light that tells you everything will be fine — nobody can give you that. But the light that shows you the next step, and the one after, so that the darkness ahead feels a little less absolute.

I have not forgotten it.


26th July 2017 — 15:00

The CT-scan.

It begins before you even arrive at the machine. Thirty minutes before, you drink water — a specific amount, at a specific time. The body must be prepared. Even the preparation has a protocol.

Then the injection. A contrast fluid, sent directly into the bloodstream through the aorta — to make the invisible visible, to help the machine detect anything abnormal moving through the blood circulation. You feel it enter you. A strange warmth, spreading inward.

Before you lie down, you remove everything metal. Watch, belt, coins — anything that belongs to the ordinary world stays outside. There is something almost ceremonial about it. You leave yourself behind, piece by piece, before entering.

And then the machine itself — a large white tube, enormous and very still. Your body slides inside it. The technicians speak to you through the air: breathe in, hold, breathe out. You do as you are told, because what else is there to do?

The machine reads you in a language you will never speak. It sees what you cannot see. It maps the inside of you with a precision that is almost impossible to imagine.

You dress again. You put the ordinary world back on.

You go home. You wait.


1st August 2017 — 10:00

Two things on the same morning, in the same enormous building.

First, the blood samples — blodprovtagning. The hospital laboratory needed them at least a week before I would see the doctor. I took my queue ticket and sat in the waiting room. Ten, maybe twenty minutes. Ordinary waiting — the kind with plastic chairs and a number and a clock that moves by seconds you can hear.

Then I crossed the building to find the right room for the second thing.

The bone marrow biopsy — benmärgsprovtagning.

There was a short queue here too. But this waiting was different. You could hear, faintly, the rhythm of it — each patient called in, five to ten minutes inside, then out. Five to ten minutes. Then the next name. Then the next.

You sat and you counted. You knew what the rhythm meant.

And then I heard my own name called.

Agus.

I went into a quiet room. I remember the quiet very specifically. And in that quiet, I became aware of my own heartbeat — not because it was racing, but because the silence was deep enough to hear it.

A nurse specialist was there. He explained the procedure with a calm that I appreciated, even as the words settled over me:

“I have to insert a small needle around your backbone. Just a little pain.”

A small needle. Just a little pain.

The needle had to enter at a precise point — along the line of the backbone, directly behind the navel. A specific dot. A location the body does not know it has until someone finds it.

I sat in the patient’s chair and took off my shirts. All of them. The back exposed, the spine visible, the body reduced to its simplest form — just a person, just a backbone, just a precise dot that had to be found.

He found the point. He was right that it was precise. He was also right, in his way, about the pain — it was not what I had feared. But it was not nothing, either. It was the feeling of being reached into, of something being taken from the deepest part of you.

They were looking all the way inside now. There was nowhere left to look after this.

I dressed again. I walked back out into the corridor of Karolinska Huddinge.

I knew enough to understand that what they had been searching for was serious.

I had let them search.


The summer was still outside. Still ordinary. Still bright.

But somewhere inside a system I could not see, the results were now travelling — from the laboratory, from the machine, from the bone — toward a room where a doctor was waiting to read them.

I went home. I waited.

One more week.


Episode 3: The Day She Wrote It Down →


EPISODES

Testimony — Episode 1: The Body Knew First

EN SV
Testimony · A Blog Series by AbeArtsSweden

There are things your body tries to tell you long before the doctors find the words.

Mine started speaking quietly. A slight pressure. A slowness. Something in the rhythm of ordinary days that had changed without asking my permission. I thought it was age. That is what we think first, when the body begins to speak — we blame the years, and we move on.

I went to the doctor. He said: prostate. Benign. Common. He scheduled an operation for a Tuesday.

I had the operation. It was routine. The kind of thing that gets scheduled and then forgotten, like a small errand you cross off a list.

But something was found.


I remember sitting in his room after the operation. A short silence first. Then the doctor said, calmly: “We found something abnormal in your urine.”

“Ow,” I thought. “Perhaps my sperms blended with the urine.” Something simple like that. Something that could be explained and fixed.

But no. It was not that kind of thing. He gave me a longer explanation — medical words I did not fully understand. I listened carefully and pretended to know what he was saying. I did not want him to think I was lost. But I was lost.

Finally I asked him: “What is this you are talking about? Can you spell the words?”

He looked around, found a piece of paper, and wrote:

Lymfom.

A word written in a doctor’s handwriting that I had never seen before, on a paper I was not prepared to receive.

A paper is just paper.
Until it holds a word
that holds your life —
the way a hand holds water:
briefly,
and with great care.

I went home with that piece of paper in my pocket. I knew I began to worry a lot.


It was almost dark cloudy on Thursday, April 6th, 2017. My wife was home. I sat in the sova in the living room of our apartment and opened my MacBook on the table before me and started to browse ‘Lymphoma’. I had to find out this alone.

The internet gave me everything and nothing at the same time.

I learned that Lymphoma was not one thing — it was a family. A large, complicated family with many branches, many names, many different futures. Some branches were slower. Some were faster. Some had treatments that worked well. Others did not.

I did not know yet which branch was mine.

I kept reading. One page. Then another. Then another. The apartment was quiet. My wife was home, but the MacBook was mine, and the search was mine, and the worry — the worry was entirely mine.

Outside, April in Sweden was doing what it does. Cold. Grey. The kind of evening that offers nothing to hold on to.

I closed the MacBook eventually. Not because I had found what I was looking for. But because I could not find it yet. The full name — the specific branch, the specific diagnosis — that would come later. From a different doctor. In a different hospital. On a different piece of paper.

That night I went to sleep with one word in my head.

Lymfom.

One word. Written on a piece of paper. Sitting in my pocket like a stone.


I am writing this in 2026. Almost nine years later.

I am writing this because I survived — and survival, I have learned, carries its own kind of obligation. Not to explain everything. Not to have all the answers. But to turn around, face the road you walked, and say to whoever is standing somewhere behind you on that same road:

I see you. I know this path. Keep walking.

This is not a story about cancer.

It is a story about what it means to be human — in a country I had chosen — and never left — inside a body that surprised me, in a place that gave me healthcare but could not give me someone to hold my hand. About sitting in a sova with a MacBook and a word I cannot fully spell yet. About the particular loneliness of facing something enormous — even when the person I love is in the next room.

The story is still being written.

Episode 2: The Weight of Waiting →

If you are facing something similar — at any stage — I hope this first episode gives you one thing:

The certainty that you are not alone. 🌸
AbeArtsSweden · Soft Power. Strong Message.
Vittnesmål · En bloggserie av AbeArtsSweden
Avsnitt 1 · Kroppen Visste Först

Det finns saker som kroppen försöker berätta för dig långt innan läkarna hittar orden.

Min började tala tyst. Ett lätt tryck. En långsamhet. Något i vardagens rytm som hade förändrats utan att be om lov. Jag tänkte att det var åldern. Det är vad vi tänker först, när kroppen börjar tala — vi skyller på åren och går vidare.

Jag gick till läkaren. Han sa: prostata. Godartad. Vanlig. Han bokade en operation till en tisdag.

Jag genomgick operationen. Det var rutinmässigt. Den sortens sak som bokas in och sedan glöms bort, som ett litet ärende man stryker från en lista.

Men något hittades.


Jag minns att jag satt i hans rum efter operationen. En kort tystnad först. Sedan sa läkaren, lugnt: “Vi hittade något onormalt i ditt urin.”

“Åh,” tänkte jag. “Kanske mina spermier blandades med urinen.” Något enkelt som det. Något som kunde förklaras och åtgärdas.

Men nej. Det var inte den sortens sak. Han gav mig en längre förklaring — medicinska ord som jag inte riktigt förstod. Jag lyssnade noga och låtsades förstå vad han sa. Jag ville inte att han skulle tro att jag var vilse. Men jag var vilse.

Till slut frågade jag: “Vad är det du pratar om? Kan du stava orden?”

Han såg sig omkring, hittade ett papper och skrev:

Lymfom.

Ett ord skrivet med en läkares handstil som jag aldrig sett förut, på ett papper jag inte var förberedd på att ta emot.

Ett papper är bara papper.
Tills det bär ett ord
som bär ditt liv —
som en hand som håller vatten:
kort,
och med stor omsorg.

Jag gick hem med det pappret i fickan. Jag visste att jag började oroa mig mycket.


Det var nästan mörkt och molnigt på torsdagen den 6 april 2017. Min fru var hemma. Jag satt i soffan i vardagsrummet i vår lägenhet och öppnade min MacBook på bordet framför mig och började söka på ‘Lymfom’. Jag var tvungen att ta reda på detta ensam.

Internet gav mig allt och ingenting på samma gång.

Jag lärde mig att Lymfom inte var en sak — det var en familj. En stor, komplicerad familj med många grenar, många namn, många olika framtider. Vissa grenar var långsammare. Andra snabbare. Vissa hade behandlingar som fungerade bra. Andra inte.

Jag visste ännu inte vilken gren som var min.

Jag fortsatte att läsa. En sida. Sedan en till. Sedan en till. Lägenheten var tyst. Min fru var hemma, men MacBooken var min, och sökningen var min, och oron — oron var helt och hållet min.

Utanför höll april i Sverige på med det den brukar göra. Kallt. Grått. Den sortens kväll som inte erbjuder något att hålla sig i.

Till slut stängde jag MacBooken. Inte för att jag hade hittat vad jag letade efter. Men för att jag inte kunde hitta det ännu. Det fullständiga namnet — den specifika grenen, den specifika diagnosen — det skulle komma senare. Från en annan läkare. På ett annat sjukhus. På ett annat papper.

Den natten somnade jag med ett ord i huvudet.

Lymfom.

Ett ord. Skrivet på ett papper. Sittande i min ficka som en sten.


Jag skriver detta 2026. Nästan nio år senare.

Jag skriver detta för att jag överlevde — och att överleva, har jag lärt mig, bär på sin egen sorts skyldighet. Inte att förklara allt. Inte att ha alla svar. Men att vända sig om, möta vägen man gått, och säga till den som någonstans står bakom dig på samma väg:

Jag ser dig. Jag känner den här stigen. Fortsätt gå.

Det här är inte en berättelse om cancer.

Det är en berättelse om vad det innebär att vara människa — i ett land jag hade valt — och aldrig lämnat — i en kropp som överraskade mig, i ett land som gav mig sjukvård men inte kunde ge mig någon som höll min hand. Om att sitta i en soffa med en MacBook och ett ord jag inte riktigt kan stava ännu. Om den särskilda ensamheten i att bära något enormt — även när den jag älskar är i rummet bredvid.

Berättelsen skrivs fortfarande.

Avsnitt 2: Väntandets tyngd →

Om du befinner dig i en liknande situation — i vilket skede som helst — hoppas jag att det här första avsnittet ger dig en sak:

Vissenheten om att du inte är ensam. 🌸
AbeArtsSweden · Soft Power. Strong Message.
EPISODES